Existing fetal monitoring devices predominantly rely on ultrasound technology, which presents several challenges, including its high sensitivity to sensor positioning, the requirement for ultrasound gel, the bulky equipment design and the limited mobility for expectant mothers while using the system and the time-consuming setup and frequent readjustments by healthcare personnel. VidaSense utilises Non-Invasive fetal Electrocardiogram (NIfECG) technology, offering reduced sensitivity to sensor positioning, decreased reliance on healthcare professional intervention, enhanced mobility for expectant mothers, making it an ideal candidate for a remote monitoring solution. Our founding team combines MedTech innovation experts with distinguished obstetric specialists, creating a unique team.
